Glaxo’s Stiefel Unit Loses $1.5 Million Verdict on Buybacks
Timothy Finnerty won the judgment on May 16 in federal court in Miami against Stiefel and its former chief executive officer, Charles Stiefel. Finnerty was the first to go to trial over claims against Stiefel, based in Coral Gables , Florida, and once the world’s largest private maker of dermatology products.

Glaxo’s Stiefel Unit Loses $1.5 Million Verdict on Buybacks


Jury rules against Stiefel on alleged stock deceit
In the fall of 2008, employees of the up-and-coming Stiefel Labs in Coral Gables received a notice about their company-stock plan. Instead of keeping their shares in the private company, workers were free to cash out and invest in any stock they wanted.

Jury rules against Stiefel on alleged stock deceit


Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
RESEARCH TRIANGLE PARK, N.C., May 11, 2012 /PRNewswire/ -- Stiefel, a GSK (GSK) company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior ...

Stiefel receives US FDA approval of Fabior™ Foam, 0.1%


David Sedaris appearance added to Stiefel Theatre slate
Salina’s Stiefel Theatre has added comedic author David Sedaris to its list of shows that was initially announced last week.

David Sedaris appearance added to Stiefel Theatre slate


Stiefel receives U.S. FDA approval of Fabior foam, 0.1%
Stiefel, a GSK company announced that the US Food and Drug Administration has approved the New Drug Application for Fabior (tazarotene) Foam, 0.1%. It is the only retinoid in a topical foam formulation ...

Stiefel receives U.S. FDA approval of Fabior foam, 0.1%